X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (59) 59
humans (48) 48
female (32) 32
oncology (29) 29
male (26) 26
middle aged (25) 25
adult (24) 24
aged (18) 18
chemotherapy (16) 16
mass spectrometry (16) 16
treatment outcome (16) 16
biochemistry & molecular biology (15) 15
cancer (14) 14
disease-free survival (14) 14
survival (13) 13
therapy (12) 12
brain neoplasms - drug therapy (11) 11
chemistry, physical (11) 11
kaplan-meier estimate (11) 11
amino acid sequence (10) 10
analysis (10) 10
animals (10) 10
proteins (10) 10
temozolomide (10) 10
bevacizumab (9) 9
brain neoplasms - mortality (9) 9
dacarbazine - analogs & derivatives (9) 9
glioblastoma - drug therapy (9) 9
molecular sequence data (9) 9
original (9) 9
oxaliplatin (9) 9
retrospective studies (9) 9
surgery (9) 9
young adult (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
care and treatment (8) 8
electrochemistry (8) 8
electrodes (8) 8
glioblastoma (8) 8
colorectal cancer (7) 7
combined modality therapy (7) 7
elektrode (7) 7
materials science, multidisciplinary (7) 7
physics, atomic, molecular & chemical (7) 7
software (7) 7
time factors (7) 7
activation (6) 6
anatase (6) 6
binding (6) 6
bor (6) 6
clinical neurology (6) 6
clinical trials (6) 6
computer science, software engineering (6) 6
dacarbazine - therapeutic use (6) 6
glioblastoma - mortality (6) 6
identification (6) 6
irinotecan (6) 6
mutation (6) 6
pediatrics (6) 6
spectroscopy (6) 6
trial (6) 6
abridged index medicus (5) 5
adolescent (5) 5
animation (5) 5
antineoplastic agents - therapeutic use (5) 5
biochemical research methods (5) 5
biophysics (5) 5
brain neoplasms - pathology (5) 5
brain neoplasms - radiotherapy (5) 5
cancer therapies (5) 5
cell (5) 5
chemistry, analytical (5) 5
chemotherapy, adjuvant (5) 5
children (5) 5
colorectal neoplasms - pathology (5) 5
drug therapy, combination (5) 5
elektron (5) 5
films (5) 5
fluorouracil (5) 5
functionalization (5) 5
gastroenterology (5) 5
glioblastoma - radiotherapy (5) 5
glioblastoma multiforme (5) 5
hydrogen (5) 5
hydrogen-ion concentration (5) 5
leucovorin (5) 5
liver neoplasms - secondary (5) 5
mass-spectrometry (5) 5
models, molecular (5) 5
nanocrystalline diamond (5) 5
original article (5) 5
original articles (5) 5
peptides (5) 5
photocurrent (5) 5
physics (5) 5
prospective studies (5) 5
quality-of-life (5) 5
radiotherapy (5) 5
research (5) 5
resolution (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Analytical Chemistry, ISSN 0003-2700, 06/2010, Volume 82, Issue 11, pp. 4648 - 4651
Journal Article
Applied Clay Science, ISSN 0169-1317, 03/2017, Volume 137, pp. 6 - 10
In a series of our previously published papers, we reported a broad range of experiments and theoretical studies devoted to the interaction of carbon dioxide... 
Clay | Carbon dioxide | Oxygen exchange | FTIR spectroscopy | Surface | FRACTIONATION | CHEMISORPTION | FIR spectroscopy | LASER | MATERIALS SCIENCE, MULTIDISCIPLINARY | CO2 | CHEMISTRY, PHYSICAL | ADSORPTION | MIXTURES | MARTIAN REGOLITH | TEMPERATURE-PROGRAMMED DESORPTION | MARS | MINERALOGY
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2014, Volume 370, Issue 8, pp. 709 - 722
In patients with glioblastoma, the addition of bevacizumab to radiotherapy and temozolomide induction therapy and the use of bevacizumab maintenance therapy... 
CONCOMITANT RADIOCHEMOTHERAPY | MEDICINE, GENERAL & INTERNAL | PHASE-II TRIAL | RECURRENT GLIOBLASTOMA | CLINICAL-TRIALS | MALIGNANT GLIOMAS | QUALITY-OF-LIFE | RESPONSE ASSESSMENT CRITERIA | MULTIFORME | HIGH-GRADE GLIOMA | ENDOTHELIAL GROWTH-FACTOR | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Induction Chemotherapy | Male | Glioblastoma - radiotherapy | Bevacizumab | Young Adult | Dacarbazine - analogs & derivatives | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Brain Neoplasms - mortality | Brain Neoplasms - radiotherapy | Angiogenesis Inhibitors - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Kaplan-Meier Estimate | Combined Modality Therapy | Brain Neoplasms - drug therapy | Disease-Free Survival | Quality of Life | Aged | Glioblastoma - drug therapy | Glioblastoma - mortality | Dosage and administration | Research | Temozolomide | Drug therapy, Combination | Drug therapy | Glioblastoma multiforme | Nuclear magnetic resonance--NMR | Intravenous administration | Glucocorticoids | Brain cancer | Body weight | Glioblastoma | Radiation therapy | Survival | Patients | Quality of life | Vascular endothelial growth factor | Index Medicus | Abridged Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
The FEBS Journal, ISSN 1742-464X, 11/2008, Volume 275, Issue 22, pp. 5589 - 5606
Journal Article
BBA - General Subjects, ISSN 0304-4165, 01/2020, Volume 1864, Issue 1, p. 129458
The Hsp70 proteins maintain proteome integrity through the capacity of their nucleotide- and substrate-binding domains (NBD and SBD) to allosterically regulate... 
Allostery | Mutation | Molecular chaperones | Folding | Heat-shock protein 70
Journal Article
BBA - Proteins and Proteomics, ISSN 1570-9639, 04/2019, Volume 1867, Issue 4, pp. 376 - 381
Germline mutations in NUDT15 cause thiopurine intolerance during treatment of leukemia or autoimmune diseases. Previously, it has been shown that the mutations... 
H/D exchange | Pharmacogenomic variants | Thiopurine metabolism | Structural mass spectrometry | NUDT15 | DIVERSE | BIOCHEMISTRY & MOLECULAR BIOLOGY | FUTURE | VARIANT | MASS-SPECTROMETRY | CHILDREN | BIOPHYSICS | COMMON | PHARMACOGENETICS | Enzymes | Molecular genetics | Proteolysis | Analysis | Leukemia | Genetic aspects | Mass spectrometry
Journal Article
Applied Clay Science, ISSN 0169-1317, 03/2017, Volume 137, p. 6
In a series of our previously published papers, we reported a broad range of experiments and theoretical studies devoted to the interaction of carbon dioxide... 
Clay minerals | Carbon dioxide
Journal Article
ACM Transactions on Graphics (TOG), ISSN 0730-0301, 07/2017, Volume 36, Issue 4, pp. 1 - 14
We present a novel physics-based approach to facial animation. Contrary to commonly used generative methods, our solution computes facial expressions by... 
facial animation | anatomical models | rigging | 3D avatar creation | Facial animation | Rigging | Anatomical models | COMPUTER SCIENCE, SOFTWARE ENGINEERING | RECONSTRUCTION
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2018, Volume 379, Issue 25, pp. 2395 - 2406
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2010, Volume 28, Issue 12, pp. 2051 - 2057
Journal Article
by Weller, Michael and Butowski, Nicholas and Tran, David D and Recht, Lawrence and Recht, Lawrence D and Lim, Michael and Hirte, Hal and Ashby, Lynn and Mechtler, Laszlo and Goldlust, Samuel and Goldlust, Samuel A and Iwamoto, Fabio and Drappatz, Jan and O'Rourke, James and O'Rourke, Donald M and Wong, Mark and Hamilton, Mark G and Hamilton, Mark and Finocchiaro, Gaetano and Perry, James and Wick, Wolfgang and Green, Jennifer and He, Yi and Turner, Christopher D and Yellin, Michael J and Keler, Tibor and Davis, Thomas A and Stupp, Roger and Sampson, John H and Campian, Jian and Becker, Kevin and Barnett, Gene and Nicholas, Garth and Desjardins, Annick and Benkers, Tara and Wagle, Naveed and Groves, Morris and Kesari, Santosh and Horvath, Zsolt and Merrell, Ryan and Curry, Richard and Schuster, David and Mrugala, Maciej and Jensen, Randy and Trusheim, John and Lesser, Glenn and Belanger, Karl and Sloan, Andrew and Purow, Benjamin and Fink, Karen and Raizer, Jeffrey and Schulder, Michael and Nair, Suresh and Peak, Scott and Brandes, Alba and Mohile, Nimish and Landolfi, Joseph and Olson, Jon and Jennens, Ross and DeSouza, Paul and Robinson, Bridget and Crittenden, Marka and Shih, Kent and Flowers, Alexandra and Ong, Shirley and Connelly, Jennifer and Hadjipanayis, Costas and Giglio, Pierre and Mott, Frank and Mathieu, David and Lessard, Nathalie and Sepulveda, Sanchez Juan and Lövey, József and Wheeler, Helen and Inglis, Po-Ling and Hardie, Claire and Bota, Daniela and Lesniak, Maciej and Portnow, Jana and Frankel, Bruce and Junck, Larry and Thompson, Reid and Berk, Lawrence and McGhie, John and Macdonald, David and Saran, Frank and Soffietti, Riccardo and Blumenthal, Deborah and André de, Sá Barreto Costa Marcos and Nowak, Anna and Singhal, Nimit and Hottinger, Andreas and Schmid, Andrea and Srkalovic, Gordan and Baskin, David and Fadul, Camilo and Nabors, Louis and LaRocca, Renato and Villano, John and Paleologos, Nina and ... and ACT IV Trial Investigators and ACT IV trial investigators
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1373 - 1385
Rindopepimut (also known as CDX-110), a vaccine targeting the deletion mutation EGFRvIII, consists of an EGFRvIII-specific peptide conjugated to keyhole limpet... 
GLIOMAS | ONCOLOGY | RECURSIVE PARTITIONING ANALYSIS | GROWTH-FACTOR | RADIOTHERAPY | CANCER | PEPTIDE | ADJUVANT TEMOZOLOMIDE | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Brain Neoplasms - pathology | ErbB Receptors - genetics | Gene Expression Regulation, Neoplastic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Patient Selection | Dose-Response Relationship, Drug | Young Adult | Glioblastoma - genetics | Time Factors | Dacarbazine - analogs & derivatives | Adult | Female | Vaccines, Subunit - adverse effects | Brain Neoplasms - mortality | Dacarbazine - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cancer Vaccines - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Neoplasms - genetics | Cancer Vaccines - adverse effects | Treatment Outcome | Brain Neoplasms - drug therapy | Disease-Free Survival | Internationality | Vaccines, Subunit - administration & dosage | Glioblastoma - pathology | Survival Analysis | Aged | Temozolomide | Glioblastoma - drug therapy | Glioblastoma - mortality | Antimitotic agents | Clinical trials | Care and treatment | Product development | Antineoplastic agents | Glioblastoma multiforme | Analysis
Journal Article